Search
for

    Sort by

    Research 151–180 of 1000+

    1. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome Clinical Endocrinology · 2019 · 30 citations
    2. Gender differences in skin: A review of the literature Gender Medicine · 2007 · 152 citations
    3. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Fertility and Sterility · 2010 · 145 citations
    4. An Unusual Case of Elevated Testosterone: When Testosterone by Dialysis Saves the Day Cureus · 2025
    5. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021 · 36 citations
    6. Effectiveness of the Mentha spicata leaves in reducing testosterone levels and aggressive behaviour in female Wistar albino rats treated with testosterone propionate Journal of Applied and Natural Science · 2024
    7. Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study Research Square (Research Square) · 2025
    8. Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance Archives of Women s Mental Health · 2024
    9. Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: an exploratory study Cutaneous and Ocular Toxicology · 2014 · 13 citations
    10. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Journal of Obstetrics and Gynaecology Research · 2007 · 16 citations
    11. EFFICACY OF FLAXSEED CRACKERS IN AMELIORATING CLINICAL AND BIOCHEMICAL HYPERANDROGENISM IN YOUNG ADULT SOUTH INDIAN WOMEN DIAGNOSED WITH PCOS Journal of Experimental Biology and Agricultural Sciences · 2021 · 1 citations
    12. Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome Journal of Contemporary Medicine · 2025
    13. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome? Ginekologia Polska · 2022 · 15 citations
    14. Kisspeptin and LH pulsatile temporal coupling in PCOS patients Endocrine · 2018 · 49 citations
    15. Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient International journal of reproduction, contraception, obstetrics and gynecology · 2017 · 3 citations
    16. The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia Gynecological Endocrinology · 2011 · 15 citations
    17. Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 9 Days in Normal Men With Experimental Hypogonadism International Journal of Andrology · 2012 · 7 citations
    18. Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review Journal of Ovarian Research · 2020 · 41 citations
    19. Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS) International Journal of Research · 2020
    20. Features of hyperandrogenism in men Problemy e̊ndokrinologii · 2021 · 1 citations
    21. The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study Physiological Research · 2016 · 14 citations
    22. Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome Physiological Research · 2019 · 13 citations
    23. Investigation Bisphenol A and Phthalate Levels in Idiopathic Hyperandrogenemia Turkish Society of Clinical Biochemistry · 2024
    24. Assessment of polycystic ovary syndrome (PCOS) occurrences among adolescent and young reproductive age group women in Tiruchirappalli District International Journal of Zoology and Applied Biosciences · 2025
    25. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria Fertility and Sterility · 2009 · 118 citations
    26. <i>Polycystic Ovary Syndrome in Adolescence</i> Annals of the New York Academy of Sciences · 2008 · 85 citations
    27. PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA Clinical Endocrinology · 1990 · 32 citations
    28. Low sex-hormone binding globulin levels in young women with diffuse hair loss British Journal of Dermatology · 1982 · 40 citations
    29. A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women Archives of Gynecology and Obstetrics · 2010 · 17 citations
    30. Women with clinically significant hirsutism always have detectable endocrinological abnormalities Journal of The European Academy of Dermatology and Venereology · 1997 · 1 citations